A specialty clinical-stage pharmaceutical company focused on developing and repurposing cannabinoid-based drugs for conditions such as Tourette syndrome, Obstructive Sleep Apnea, Mild Cognitive Impairment, Traumatic Brain Injury, and infectious diseases.